Synovial fluids from 6 of 12 patients with rheumatoid arthritis (RA) and from 3 of 11 patients with reactive arthritis contained measurable levels of tumor necrosis factor a (TNFa). Seven of 12 sera from RA patients contained TNFa, while only 1 of those from reactive arthritis patients was positive.
ELISA for quantitation of tumor necrosis factor-α in serum
✍ Scribed by W.S. Prince; K.J. Harder; S. Saks; B.R. Reed; A.B. Chen; A.J.S. Jones
- Book ID
- 103910925
- Publisher
- Elsevier Science
- Year
- 1987
- Tongue
- English
- Weight
- 467 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0731-7085
No coin nor oath required. For personal study only.
✦ Synopsis
A sensitive and precise ELISA has been developed for the quantitation of recombinant Tumor Necrosis Factor-Alpha (rTNF-a) in undiluted sera. Affinity purified rabbit antibody was used as capture antibody and mouse monoclonal antibody labelled with horseradish peroxidase was used as the second antibody in a sandwich ELISA. The assay range was from 50 to 2000 pg/ml and the relative standard deviation was 8% or less for both interassay and intra-assay precision studies. Recovery of rTNFet added to 10 different human and 10 different monkey sera ranged from 81 to 102% and 100 to 120% of the expected value, respectively.
This ELISA has been used to measure serum rTNF-oL levels in over 60 patients in Phase I Clinical Trials treated with rTNF-a. The levels in a representative, pharmacokinetic study showed low variability between 8 patients receiving intravenous bolus administration of 100 txg rTNF-edm 2. The ELISA results correlated well with TNF bioassay data with a mean specific activity of 2.5 x 107 U/rag.
📜 SIMILAR VOLUMES